↓ Skip to main content

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients

Overview of attention for article published in Frontiers in Cardiovascular Medicine, May 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
14 Mendeley